adamantane has been researched along with amphetamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Nardo, M; Fabrissin, S; Runti, C | 1 |
| Beninger, RJ; Ranaldi, R | 1 |
| Acquas, E; Fibiger, HC | 1 |
| Bérod, A; Colussi-Mas, J; Lambás-Señas, L; Panayi, F; Renaud, B; Scarna, H | 1 |
| Button, D; Feifel, D; Melendez, G; Pang, Z; Schreiber, R; Shilling, PD | 1 |
| Binder, EB; Cáceda, R; Kinkead, B; Nemeroff, CB | 1 |
| Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH; Raoof, H; Silberring, J; Suder, P | 1 |
7 other study(ies) available for adamantane and amphetamine
| Article | Year |
|---|---|
[Antiviral chemotherapeutic agents. XVIII. Adamantane derivatives of amphetamine. Their potential interest as autonomic and antiparkinson agents].
Topics: Adamantane; Amphetamine; Amphetamines; Antiparkinson Agents; Antiviral Agents; Autonomic Agents; Central Nervous System; Chemical Phenomena; Chemistry; Hydrazines | 1975 |
The effects of systemic and intracerebral injections of D1 and D2 agonists on brain stimulation reward.
Topics: Adamantane; Amphetamine; Animals; Benzopyrans; Caudate Nucleus; Dopamine Agonists; Electric Stimulation; Ergolines; Male; Nucleus Accumbens; Putamen; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward; Tegmentum Mesencephali | 1994 |
Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition.
Topics: Acetylcholine; Acetylcholinesterase; Adamantane; Amphetamine; Animals; Benzopyrans; Cholinesterase Inhibitors; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Microdialysis; Neostigmine; Quinpirole; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1998 |
Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization.
Topics: Adamantane; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Imidazoles; Injections, Subcutaneous; Male; Microinjections; Motor Activity; Neurotensin; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Ventral Tegmental Area | 2005 |
Sensorimotor gating in neurotensin-1 receptor null mice.
Topics: Acoustic Stimulation; Adamantane; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Dizocilpine Maleate; Dose-Response Relationship, Drug; Female; Indoles; Mice; Mice, Knockout; Neural Inhibition; Neuroprotective Agents; Receptors, Neurotensin; Reflex, Startle; Sensory Gating | 2010 |
The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
Topics: Acoustic Stimulation; Adamantane; Amphetamine; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Gait Disorders, Neurologic; Gene Expression Regulation; Imidazoles; Male; Neurotensin; Proto-Oncogene Proteins c-fos; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Reflex, Startle; RNA, Messenger | 2012 |
Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats.
Topics: Adamantane; Amphetamine; Animals; Anxiety; Behavior, Animal; Conditioning, Psychological; Dipeptides; Dose-Response Relationship, Drug; Male; Maze Learning; Oligopeptides; Rats; Rats, Wistar; Receptors, Neuropeptide; Substance Withdrawal Syndrome | 2012 |